Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 AIDS Related Kaposi's ... Read More
-
Gallbladder Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gallbladder Cancer Understanding The DelveInsight Gallbladder Cancer ... Read More
-
Peripheral T cell Lymphoma - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Peripheral T cell ... Read More
-
Advanced Breast Cancer In Premenopausal Women - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
KRAS Mutant Cancer - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 KRAS Mutant Cancer Understanding The ... Read More
-
Hairy Cell Leukemia - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Hairy Cell Leukemia Understanding The ... Read More
-
Fallopian Tube Cancer - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Fallopian Tube Cancer Understanding The ... Read More
-
Muscle Invasive Bladder cancer - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Muscle Invasive Bladder ... Read More
-
MALT Lymphoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 MALT Lymphoma Understanding The DelveInsight MALT Lymphoma ... Read More
-
Cancer Therapy Related Diarrhea - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cancer Therapy Related ... Read More
-
Small Cell Lung Cancer - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Small Cell Lung ... Read More
-
Acute Lymphoblastic Leukemia Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Acute Lymphoblastic Leukemia Understanding The ... Read More
-
Oropharyngeal Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Oropharyngeal Cancer Understanding The DelveInsight Oropharyngeal Cancer ... Read More
-
HER2-Positive Early Breast Cancer - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER2-Positive Early Breast ... Read More
-
Cancer Cachexia (CC)– Epidemiology Forecast—2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cancer Cachexia (CC) Understanding The ... Read More
-
HER2+ Non Small Cell Lung Cancer - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2022
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Soft Tissue Sarcoma (STS) with lung metastases - Market Insight, Epidemiology and Market Forecast -2032
... well as the Soft Tissue Sarcoma (STS) with lung metastases market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Soft Tissue Sarcoma (STS) with lung metastases market ... Read More
-
Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2030
... Demand Analysis & Opportunity Outlook 2030 Market Overview Fatpos Global has released a report titled Women’s Health Diagnostics Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. ... Read More
-
Ewing Sarcoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Ewing Sarcoma Understanding The DelveInsight Ewing Sarcoma ... Read More
-
Rhabdomyosarcoma - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Rhabdomyosarcoma Understanding The DelveInsight Rhabdomyosarcoma epidemiology report gives a ... Read More
-
Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026
... And Saliva), By Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, Circulating Free DNA, And Others), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, And Others), By Technique (Polymerase Chain Reaction And Next Generation ... Read More
-
The Market for Liquid Biopsy
... Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market ... Read More
-
Cancer Anorexia - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cancer Anorexia market report provides current treatment practices, emerging drugs, Cancer Anorexia market share of the individual therapies, current and forecasted Cancer Anorexia ... Read More
-
Ovarian Cancer - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ovarian Cancer market report provides current treatment practices, emerging drugs, Ovarian Cancer market share of the individual therapies, current and forecasted Ovarian Cancer ... Read More
Research Assistance
